Skip to main content
Erschienen in: Supportive Care in Cancer 6/2009

01.06.2009 | Original Article

Indicators of surgery and survival in oncology inpatients requiring surgical evaluation for palliation

verfasst von: Brian D. Badgwell, Kerrington Smith, Ping Liu, Eduardo Bruera, Steven A. Curley, Janice N. Cormier

Erschienen in: Supportive Care in Cancer | Ausgabe 6/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

We sought to determine the clinical presentation, management, and outcomes associated with surgical consultation for symptom palliation in oncology inpatients.

Materials and methods

We reviewed the medical records of inpatients for whom surgical consultations were requested (January 2000 to September 2006) at a tertiary referral cancer center to identify those who underwent surgical palliative evaluation (defined as consultation for symptoms attributable to an advanced or incurable malignancy). We used the Cox proportional hazards model to identify prognostic factors associated with overall survival (OS) and logistic regression to identify factors associated with surgical intervention.

Results

Surgical consultation was requested for 1,102 inpatients; 442 (40%) met the criteria for surgical palliative evaluation. Gastrointestinal obstruction was the most common complaint (43%), while wound complications/infection and gastrointestinal bleeding accounted for 10% and 8%, respectively. The median OS was 2.9 months. Adverse prognostic factors for OS included ≥2 radiologically evident disease sites (HR = 1.4; 95% CI, 1.1–1.8) and carcinomatosis/sarcomatosis (HR = 1.4; 95% CI, 1.1–1.7). Palliative surgical procedures were performed in 119 (27%) patients, with a 90-day morbidity and mortality rate of 40% and 7% respectively. Patients with wound complications (OR = 3.3; 95% CI, 1.4–7.6), intestinal obstruction (OR = 1.9; 95% CI, 1.1–3.2), or an intact primary/recurrent tumor (OR = 3.6; 95% CI, 2.2–6.0) were more likely to undergo surgical intervention. Patients with ascites were less likely to undergo surgery (OR = 0.4; 95% CI, 0.2–0.8).

Conclusions

Surgical palliative evaluations accounted for 40% of inpatient surgical consultations. Given that OS in this population is short and surgery is associated with considerable morbidity and mortality, non-operative management is desirable.
Literatur
1.
Zurück zum Zitat A predictive model for aggressive non-Hodgkin’s lymphoma. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. N Engl J Med 329:987–994. doi:10.1056/NEJM199309303291402 A predictive model for aggressive non-Hodgkin’s lymphoma. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. N Engl J Med 329:987–994. doi:10.​1056/​NEJM199309303291​402
2.
Zurück zum Zitat American Cancer Society (2007) Cancer facts and figures 2007. American Cancer Society, Atlanta American Cancer Society (2007) Cancer facts and figures 2007. American Cancer Society, Atlanta
3.
Zurück zum Zitat World Health Organization (2002) National cancer control programmes: policies and managerial guidelines, 2nd edn. World Health Organization, Geneva World Health Organization (2002) National cancer control programmes: policies and managerial guidelines, 2nd edn. World Health Organization, Geneva
4.
Zurück zum Zitat Cox D (1972) Regression models and life tables (with discussion). J Roy Stat Soc Ser B 34:187–220 Cox D (1972) Regression models and life tables (with discussion). J Roy Stat Soc Ser B 34:187–220
6.
Zurück zum Zitat Feuer DJ, Broadley KE, Shepherd JH et al (1999) Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer. The Systematic Review Steering Committee. Gynecol Oncol 75:313–322. doi:10.1006/gyno.1999.5594 PubMedCrossRef Feuer DJ, Broadley KE, Shepherd JH et al (1999) Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer. The Systematic Review Steering Committee. Gynecol Oncol 75:313–322. doi:10.​1006/​gyno.​1999.​5594 PubMedCrossRef
9.
Zurück zum Zitat Krebs HB, Goplerud DR (1983) Surgical management of bowel obstruction in advanced ovarian carcinoma. Obstet Gynecol 61:327–330PubMed Krebs HB, Goplerud DR (1983) Surgical management of bowel obstruction in advanced ovarian carcinoma. Obstet Gynecol 61:327–330PubMed
18.
Zurück zum Zitat Miner TJ, Brennan MF, Jaques DP (2004) A prospective, symptom related, outcomes analysis of 1022 palliative procedures for advanced cancer. Ann Surg 240:719–726PubMed Miner TJ, Brennan MF, Jaques DP (2004) A prospective, symptom related, outcomes analysis of 1022 palliative procedures for advanced cancer. Ann Surg 240:719–726PubMed
20.
Zurück zum Zitat Podnos YD, Juarez G, Pameijer C et al (2007) Impact of surgical palliation on quality of life in patients with advanced malignancy: results of the decisions and outcomes in palliative surgery (DOPS) trial. Ann Surg Oncol 14:922–928. doi:10.1245/s10434-006-9238-y PubMedCrossRef Podnos YD, Juarez G, Pameijer C et al (2007) Impact of surgical palliation on quality of life in patients with advanced malignancy: results of the decisions and outcomes in palliative surgery (DOPS) trial. Ann Surg Oncol 14:922–928. doi:10.​1245/​s10434-006-9238-y PubMedCrossRef
22.
Zurück zum Zitat Turnbull AD, Guerra J, Starnes HF (1989) Results of surgery for obstructing carcinomatosis of gastrointestinal, pancreatic, or biliary origin. J Clin Oncol 7:381–386PubMed Turnbull AD, Guerra J, Starnes HF (1989) Results of surgery for obstructing carcinomatosis of gastrointestinal, pancreatic, or biliary origin. J Clin Oncol 7:381–386PubMed
Metadaten
Titel
Indicators of surgery and survival in oncology inpatients requiring surgical evaluation for palliation
verfasst von
Brian D. Badgwell
Kerrington Smith
Ping Liu
Eduardo Bruera
Steven A. Curley
Janice N. Cormier
Publikationsdatum
01.06.2009
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 6/2009
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-008-0554-6

Weitere Artikel der Ausgabe 6/2009

Supportive Care in Cancer 6/2009 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.